Related Experiment Video
Updated: Jan 19, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Infrequent tacrolimus-induced nephrotoxicity in French patients with steroid-dependent nephrotic syndrome
Jean Daniel Delbet1,2, Bilal Aoun3, David Buob2,4
1Department of Pediatric Nephrology, Armand Trousseau Hospital, APHP, 26 Avenue du Docteur Arnold Netter, 75012, Paris, France.
Insights
Calcineurin inhibitors (CNI) rarely caused chronic kidney damage in children with severe idiopathic nephrotic syndrome (INS). Kidney biopsies may help detect CNI-induced lesions in patients needing long-term treatment.
Area of Science:
- Pediatric Nephrology
- Pharmacology
- Immunosuppression
Background:
- Calcineurin inhibitors (CNI) are crucial for treating severe idiopathic nephrotic syndrome (INS) in children.
- Chronic nephrotoxicity with irreversible lesions is a significant concern with CNI therapy.
- Identifying risk factors and monitoring for CNI-induced kidney damage is essential.
Purpose of the Study:
- To evaluate the incidence of chronic CNI-induced nephrotoxicity in children with steroid-dependent INS.
- To assess the utility of kidney biopsies in detecting CNI-induced lesions in this patient population.
- To inform treatment strategies and long-term management of pediatric INS.
Main Methods:
- Retrospective study of children with steroid-dependent INS on CNI for over one year.
- Inclusion of patients where CNI could not be substituted with mycophenolate mofetil.
- Analysis of kidney biopsy findings, clinical data, and treatment duration.
Main Results:
- Twenty-one children were included, with a median CNI treatment duration of 30 months.
- Minimal change disease was diagnosed in 20/21 patients; focal segmental glomerulosclerosis in 1/21.
- Chronic CNI-induced nephrotoxicity was infrequent, observed in only one patient (arteriolar hyalinosis and fibrosis).
Conclusions:
- CNI-induced chronic nephrotoxicity was uncommon in this cohort of children with INS.
- Kidney biopsies are valuable for excluding chronic CNI-induced lesions in patients requiring long-term or high-dose CNI therapy.
- This study supports careful monitoring and judicious use of CNIs in pediatric nephrotic syndrome.
Background:
Chronic nephrotoxicity with potentially irreversible lesions is a major concern regarding calcineurin inhibitor (CNI) treatment in children with severe forms of idiopathic nephrotic syndrome (INS).
Case-Diagnosis/Treatment:
We retrospectively included all children on CNI for steroid-dependent INS with a duration of CNI treatment of more than 1 year. Only patients in whom CNI could not be replaced by mycophenolate mofetil were included. All included patients underwent a kidney biopsy. All results were expressed as median and range. Twenty-one children (6 girls) were included. Age at disease onset was 49 (29-66) months and treatment duration on CNI was 30 (20-45) months. Age at kidney biopsy was 108 (78-170) months. Number of relapses was 7 (3-9) since disease onset. Serum creatinine level was transiently and moderately increased in two patients. Kidney biopsy revealed minimal change disease in 20/21 patients and focal segmental glomerulosclerosis in 1/21. Evidence for chronic CNI nephrotoxicity was found in one patient revealed by arteriolar hyalinosis and fibrosis in 50% of glomeruli.
Conclusions:
CNI-induced chronic nephrotoxicity was infrequent. In patients who require long-term and/or high-dose CNI treatment, kidney biopsies might be useful to exclude chronic CNI-induced lesions.
Related Concept Videos
Nephrotic Syndrome I : Introduction
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
08:38Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:52Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
